BNT411, a selective TLR7 agonist, induces IFNalpha release both in vivo and in vitro. With anticancer activity, BNT411 is applicable in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC) [1].
Molecular Weight:
439.55
CAS Number:
[2296821-50-4]
Formula:
C24H33N5O3
Target:
TLR
T85865
* VAT and and shipping costs not included. Errors and price changes excepted
